Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Micropapillary bladder cancer: a review of the University of Texas M D Anderson Cancer Center experience with 100 consecutive patients Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LLCancer 2007[Jul]; 110 (1): 62-7BACKGROUND: Micropapillary bladder carcinoma is a rare variant of urothelial carcinoma. To improve understanding of this disease, the authors performed a retrospective review of their experience. METHODS: The authors reviewed the records of 100 consecutive patients with micropapillary bladder cancer who were evaluated at The University of Texas M. D. Anderson Cancer Center. RESULTS: The mean age of the patients was 64.7 years, with a male:female ratio of 10:1. The TNM stage of disease at the time of presentation was Ta in 5 patients, carcinoma in situ (CIS) in 4 patients, T1 in 35 patients, T2 in 26 patients, T3 in 7 patients, T4 in 6 patients; N+ in 9 patients, and M+ in 8 patients. Kaplan-Meier estimates of 5-year and 10-year overall survival (OS) rates were 51% and 24%, respectively. Bladder-sparing therapy with intravesical bacillus Calmette-Guerin therapy was attempted in 27 of 44 patients with nonmuscle-invasive disease; 67% (18 patients) developed disease progression (>or=cT2), including 22% who developed metastatic disease. Of 55 patients undergoing radical cystectomy for surgically resectable disease (|Adult[MESH]|Aged[MESH]|Aged, 80 and over[MESH]|Carcinoma, Papillary/drug therapy/*pathology/surgery[MESH]|Carcinoma, Transitional Cell/drug therapy/*pathology/surgery[MESH]|Combined Modality Therapy[MESH]|Cystectomy/methods[MESH]|Female[MESH]|Hospitals, University[MESH]|Humans[MESH]|Male[MESH]|Middle Aged[MESH]|Neoadjuvant Therapy/methods[MESH]|Neoplasm Staging[MESH]|Retrospective Studies[MESH]|Survival Analysis[MESH]|Texas[MESH]|Urinary Bladder Neoplasms/drug therapy/*pathology/surgery[MESH] |